FDA’s ANDA Pilot: Win for U.S. Manufacturing
The FDA’s new ANDA Prioritization Pilot aims to enhance U.S. manufacturing of generic drugs by expediting approvals for domestically produced products, boosting supply resilience and patient access to affordable medications.